Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Oct 23, 2005 9:26pm
234 Views
Post# 9755020

RE: Good post carbonfibre

RE: Good post carbonfibre I am not sure if I agree with TStorm's conspiracy theory, although I do agree that any prospective bridge financing for HML will be easier at these levels. Ironically, with a $10mm cdn market cap, it MAY be cheaper for a prospective partner to try to gain control of HML via the public market, especially if they are concerned that there will be more than one party bidding in the event of receivership. Whenever you see a "value disconnect" to the degree that there is currently with HML, I think you'll see a deal as opposed to failure. Hemosol management told me that their current plant would cost $200mm and take three years to build. The land ALONE is worth close to $10mm. With approx $28mm in debt against the property, I think they have room to get a reasonable deal done. I watched the trading of both Prometic and HML quite closely on Friday subsequent to Hemosol's news. There was very little going on in PLI, if anything it seems as if there is a pretty strong underlying bid. Hemosol on the other hand saw at least one LARGE seller out of CIBC that really knocked the heck out of the market.... then all of a sudden some pretty large concentrated buying came in. This actually caught me by surprise and suggests to me that someone knows something. It was quite obvious that some big money stepped up close to the lows and really stood in... It will truly be interesting to see how this all plays out.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse